SUTRO BIOPHARMA, INC. (16)

Browse by Contract Category

Contracts

Option Agreement, dated October 9, 2021, by and between the Registrant and BioNova Pharmaceuticals Limited (Filed With SEC on February 28, 2022)
License Agreement, dated December 24, 2021. by and between the Registrant and Tasly Biopharmaceuticals Co., Ltd (Filed With SEC on February 28, 2022)
Second Amendment to the Exclusive Patent License and Research Collaboration Agreement (Filed With SEC on November 10, 2021)
Third Amendment to Lease 888-894 Industrial Road, San Carlos, CA (Filed With SEC on August 9, 2021)
Severance and Change in Control Plan (Filed With SEC on May 7, 2021)
Underwriting Agreement dated December 8, 2020 (Filed With SEC on December 9, 2020)
Offer Letter, dated December 11, 2012, by and between the Registrant and Edward C. Albini (Filed With SEC on February 28, 2022)
Offer Letter, dated May 23, 2021, by and between the Registrant and Jane Chung (Filed With SEC on February 28, 2022)
Offer Letter, dated December 11, 2015, by and between the Registrant and Arturo Molina (Filed With SEC on February 28, 2022)
Offer Letter, dated August 8, 2018, by and between the Registrant and Linda Fitzpatrick (Filed With SEC on March 18, 2021)
Severance and Change in Control Plan of the Company (Filed With SEC on March 18, 2021)
Underwriting Agreement dated May 11, 2020 (Filed With SEC on May 12, 2020)
Description of Registrants Securities (Filed With SEC on March 16, 2020)
Amended Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 8, 2019)
Amended Form of Performance Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 8, 2019)
First Amendment to Loan and Security Agreement dated December 5, 2018 among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on April 1, 2019)